New Platform Now Live, Featuring Expanded Sections on Clinical Studies, Stem Cell Therapies, Aesthetics, Media, Podcasts, Case Studies, and Investor Resources
Winter Park, Florida--(Newsfile Corp. - July 15, 2026) - Adia Med Inc. (OTCQB: ADIA), a clinical-stage regenerative medicine company, today announced the launch of its redesigned corporate website. The redesigned website is now live, with the project still in progress and active changes and improvements currently being made.
Adia Med Inc. (Formerly Adia Nutrition Inc.) Launches Redesigned Corporate Website
To view an enhanced version of this graphic, please visit:
https://images.newsfilecorp.com/files/10520/304999_1.jpg
This launch follows the Company's recent name change from Adia Nutrition Inc. to Adia Med Inc., a strategic move to better align its brand with its core focus on regenerative medicine, stem cell therapies, and advanced biologics.
The newly redesigned website at www.adiamed.com now serves as the Company's primary digital hub. It features sections on clinical studies, stem cell therapies, and aesthetics. The site also features or will feature dedicated sections for:
Media coverage and press materials
Podcasts and video interviews
Clinical case studies
Investor information and regulatory filings
Company news and additional educational resources
In addition, the former website, www.adianutrition.com, will now automatically redirect visitors to the new Adia Med website at www.adiamed.com.
"This redesigned website marks another important step forward for Adia Med Inc.," said Larry Powalisz, Chief Executive Officer. "Following our name change, we wanted a digital presence that better reflects who we are today. The new site provides clearer and more comprehensive information about our clinical studies, stem cell therapies, aesthetics offerings, and corporate developments, making it easier for patients, healthcare professionals, media, and investors to engage with us."
The updated platform is designed to improve transparency and accessibility as the Company continues to advance its clinical programs and growth initiatives.
For questions, inquiries, or additional information, please contact Larry Powalisz at ceo@adiamed.com or by phone at 321-231-2843.
About ADIA Med Inc.:
Adia Med Inc. (OTCQB: ADIA), based in Winter Park, Florida, is a publicly traded company advancing healthcare through innovation. The company specializes in sales of stem cell and regenerative products, such as AdiaVita and AdiaLink, through its lab division, Adia Labs LLC, which is expanding to include insurance-billable wound care products. Adia is also growing nationwide with Adia Med clinics, specializing in orthopedic, pain management, and wound repair. Adia Med clinics also offer specialized regenerative treatments like stem cell therapies and platelet-rich plasma (PRP), advanced treatments including therapeutic plasma exchange (TPE) and autologous hematopoietic stem cell transplantation (aHSCT), and wound repair services.